Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mirum Pharmaceuticals, Inc.

45.00
+0.96002.18%
Volume:451.05K
Turnover:20.29M
Market Cap:2.21B
PE:-24.32
High:45.66
Open:44.35
Low:43.64
Close:44.04
Loading ...
Mar 08, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 09, 2023

Major Issues Report

8-K - Current report
Dec 19, 2022

Major Issues Report

8-K - Current report
Dec 13, 2022

Major Issues Report

8-K - Current report
Dec 01, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 29, 2022

Major Issues Report

8-K - Current report
Nov 09, 2022

Major Issues Report

8-K - Current report
Nov 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 24, 2022

Major Issues Report

8-K - Current report
Sep 12, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Sep 02, 2022

Major Issues Report

8-K - Current report
Aug 18, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 16, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 10, 2022

Major Issues Report

8-K - Current report
Aug 04, 2022

Major Issues Report

8-K - Current report
Aug 04, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 02, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership